Loading…
SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.
Also known as: KARYOPHARM THERAPEUTICS INC, KARYOPHARM THERAPEUTICS INC.,, Karyopharm Therapeutics Inc.
Firm Income Reported for This Client
$280K
Not substituted for client expenses
SEC Insider
$186.2M
1,213 transactions
Summary
Karyopharm Therapeutics Inc. (KPTI) is an organization. Its political footprint includes $280K in lobbying-firm income reported for this client. Lobbying activity focuses on Pharmacy. Their largest government contract source is Department of Veterans Affairs at $0. Political activity spans from 2019 to 2026.